Cassava Sciences | PTIE - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Abbott USD 4.68B 439M 2026-03
Amgen USD 2.86B 16.65B 2026-06
Biogen USD 403.9M 45.4M 2026-06
Cara Therapeutics USD 4.62M 1.4M 2026-03
Cassava Sciences USD 39.19M 2.46M 2026-03
Eisai JPY 87.53B 11.64B 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Geron USD 8.8M 3.92M 2026-06
J&J USD 9.22B 1.24B 2026-06
Merck USD 3.83B 36M 2026-06
Novartis USD 4.26B 64M 2026-06
Novavax USD 22.94M 6.84M 2026-06
Pfizer USD 4.58B 75M 2026-06
Roche Holding CHF 5.54B 237M 2026-06